Growing community of inventors

Berlin, Germany

Anne Konkel

Average Co-Inventor Count = 6.30

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Anne KonkelRobert Fischer (3 patents)Anne KonkelJohn Russell Falck (2 patents)Anne KonkelWolf-Hagen Schunck (2 patents)Anne KonkelTim Wesser (2 patents)Anne KonkelGerd Wallukat (1 patent)Anne KonkelDominik N Mueller (1 patent)Anne KonkelChristina Westphal (1 patent)Anne KonkelJanine Lossie (1 patent)Anne KonkelDominik Müller (1 patent)Anne KonkelPhilipp Westphal (1 patent)Anne KonkelWolf-Hagen Schunk (1 patent)Anne KonkelJohn Russel Falck (1 patent)Anne KonkelPhilipp Westphal (1 patent)Anne KonkelDominik Muller (1 patent)Anne KonkelJohn Russel Falck (0 patent)Anne KonkelAnne Konkel (3 patents)Robert FischerRobert Fischer (7 patents)John Russell FalckJohn Russell Falck (34 patents)Wolf-Hagen SchunckWolf-Hagen Schunck (5 patents)Tim WesserTim Wesser (2 patents)Gerd WallukatGerd Wallukat (13 patents)Dominik N MuellerDominik N Mueller (4 patents)Christina WestphalChristina Westphal (1 patent)Janine LossieJanine Lossie (1 patent)Dominik MüllerDominik Müller (1 patent)Philipp WestphalPhilipp Westphal (1 patent)Wolf-Hagen SchunkWolf-Hagen Schunk (1 patent)John Russel FalckJohn Russel Falck (1 patent)Philipp WestphalPhilipp Westphal (1 patent)Dominik MullerDominik Muller (2 patents)John Russel FalckJohn Russel Falck (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Texas System (2 from 5,445 patents)

2. Max-delbruck-centrum Fur Molekulare Medizin (2 from 30 patents)

3. Omeicos Therapeutics Gmbh (2 from 2 patents)

4. Max-delbrueck-centrum Fuer Molekulare Medizin (1 from 18 patents)

5. Max-delbruck-centrum Fur Molekulare Medizin in Der Helmholtz-gemeinschaft (21 patents)


3 patents:

1. 12370158 - Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation

2. 11130772 - CYP-eicosanoid derivatives

3. 11096910 - Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…